APOA2 antibody (FITC)

Catalog No. ABIN7454056

The Goat Polyclonal anti-APOA2 antibody has been validated for . It is suitable to detect APOA2 in samples from Human.

Quick Overview for APOA2 antibody (FITC) (ABIN7454056)

Target: APOA2 (Apolipoprotein A-II (APOA2))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This APOA2 antibody is conjugated to FITC

Application: Please inquire

Clone: F04

Product Details anti-APOA2 Antibody (FITC)

Purpose: Goat anti-Human Apo AII [F04] Antibody FITC Conjugated

Immunogen: Human Apolipoprotein AII

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Expiry Date: 12 months

Target Details for APOA2

Target: APOA2 (Apolipoprotein A-II (APOA2))

Alternative Name: ApoAII

Background: Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)

Gene ID: 336

NCBI Accession: NP_001634

UniProt: P02652

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism